Marquette University

e-Publications@Marquette
Biomedical Engineering Faculty Research and
Publications

Biomedical Engineering, Department of

11-1-2012

Tyrosine Nitration of Voltage-dependent Anion
Channels in Cardiac Ischemia-reperfusion:
Reduction by Peroxynitrite Scavenging
Meiying Yang
Medical College of Wisconsin

Amadou K.S. Camara
Medical College of Wisconsin

Bassam T. Wakim
Medical College of Wisconsin

Yifan Zhou
Medical College of Wisconsin

Ashish K. Gadicherla
Medical College of Wisconsin
See next page for additional authors

NOTICE: this is the author’s version of a work that was accepted for publication in Biochimica et
Biophysica Acta: Bioenergetics. Changes resulting from the publishing process, such as peer review,
editing, corrections, structural formatting, and other quality control mechanisms may not be
reflected in this document. Changes may have been made to this work since it was submitted for
publication. A definitive version was subsequently published in Biochimica et Biophysica Acta:
Bioenergetics, Vol. 1817, No. 11 (November 2012): 2049-2059. DOI. © 2012 Elsevier. Used with
permission.

Authors

Meiying Yang, Amadou K.S. Camara, Bassam T. Wakim, Yifan Zhou, Ashish K. Gadicherla, Wai-Meng Kwok,
and David F. Stowe

This article is available at e-Publications@Marquette: https://epublications.marquette.edu/bioengin_fac/330

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Tyrosine Nitration of Voltage
Dependent Anion Channels In
Cardiac Ischemia-Reperfusion:
Reduction by Peroxynitrite
Scavenging
Meiying Yang
Department of Anesthesiology, Medical College of Wisconsin
Milwaukee, WI

Amadou K.S. Camara
Department of Anesthesiology, Medical College of Wisconsin
Milwaukee, WI
Cardiovascular Research Center, Medical College of Wisconsin
Milwaukee, WI

Bassam T. Wakim
Department of Biochemistry, Medical College of Wisconsin
Milwaukee, WI

Yifan Zhou
Department of Anesthesiology, Medical College of Wisconsin
Milwaukee, WI
Department of Pharmacology and Toxicology, Medical College of
Wisconsin
Milwaukee, WI

Biochimica et Biophysica Acta: Bioenergetics, Vol. 1817, No. 11 (November 2012): pg. 2049-2059. DOI. This article is ©
Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Elsevier.

1

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Ashish K. Gadicherla
Department of Anesthesiology, Medical College of Wisconsin
Milwaukee, WI

Wai-Meng Kwok
Department of Anesthesiology, Medical College of Wisconsin
Milwaukee, WI
Department of Pharmacology and Toxicology, Medical College of
Wisconsin
Milwaukee, WI

David F. Stowe
Department of Anesthesiology, Medical College of Wisconsin
Milwaukee, WI
Department of Physiology, Medical College of Wisconsin
Milwaukee, WI
Cardiovascular Research Center, Medical College of Wisconsin
Milwaukee, WI
Research Service, Veterans Affairs Medical Center
Milwaukee, WI
Department of Biomedical Engineering, Marquette University
Milwaukee, WI

Abstract
Excess superoxide (𝑂2•− ) and nitric oxide (NO•) forms peroxynitrite
(ONOO−) during cardiac ischemia reperfusion (IR) injury, which in turn
induces protein tyrosine nitration (tyr-N). Mitochondria are both a source of
and target for ONOO−. Our aim was to identify specific mitochondrial proteins
that display enhanced tyr-N after cardiac IR injury, and to explore whether
inhibiting 𝑂2•− /ONOO− during IR decreases mitochondrial protein tyr-N and
consequently improves cardiac function. We show here that IR increased tyrN of 35 and 15 kDa mitochondrial proteins using Western blot analysis with 3nitrotyrosine antibody. Immunoprecipitation (IP) followed by LC–MS/MS
identified 13 protein candidates for tyr-N. IP and Western blot identified and
confirmed that the 35 kDa tyr-N protein is the voltage-dependent anion
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channel (VDAC). Tyr-N of native cardiac VDAC with IR was verified on
recombinant (r) VDAC with exogenous ONOO−. We also found that ONOO−
directly enhanced rVDAC channel activity, and rVDAC tyr-N induced by
ONOO− formed oligomers. Resveratrol (RES), a scavenger of 𝑂2•− /ONOO−,
reduced the tyr-N levels of both native and recombinant VDAC, while L-NAME,
which inhibits NO• generation, only reduced tyr-N levels of native VDAC. 𝑂2•−
and ONOO− levels were reduced in perfused hearts during IR by RES and LNAME and this was accompanied by improved cardiac function. These results
identify tyr-N of VDAC and show that reducing ONOO− during cardiac IR injury
can attenuate tyr-N of VDAC and improve cardiac function.
Keywords: Mitochondria, Protein tyrosine nitration, Cardiac injury, VDAC,
ROS/RNS scavengers.

1. Introduction
Mitochondrial dysfunction during cardiac ischemia (I) and
reperfusion (R) injury is associated with Ca2+ overload, excess
emission of reactive oxygen species (ROS) [1–3] and reactive nitrogen
species (RNS) [4,5] that can lead to deleterious post-translational
modifications (dPTMs) of mitochondrial proteins [6]. Superoxide (𝑂2•− ),
the origin of most O2 -derived free radicals, is overproduced and under
scavenged during cardiac IR injury [1,7]. Under hypoxic or ischemic
conditions, the mitochondrial electron transport chain (ETC) is initially
in a highly reduced state [1], which results in electron leak so that O2
is reduced to 𝑂2•− . During reperfusion, 𝑂2•− production, initiated during
ischemia, is further exacerbated [1] because of diminished ADP levels,
abundant O2, and poor ROS scavenging capability. Nitric oxide (NO•),
a precursor of RNS, may also increase during IR [8,9]. When 𝑂2•− is in
excess it reacts with available NO• to generate peroxynitrite (ONOO−)
[2,10], a highly reactive non-radical and a strong marker of RNSinduced cell cytotoxicity. Indeed, a marked increase in ONOO− occurs
during cardiac IR injury [4,5] and a reduction in injury is associated
with decreased release of ONOO− [4,5]. 𝑂2•− is a charged and diffusion
limited molecule generated in mitochondria, whereas NO• is an
uncharged, and diffusible molecule that easily traverses mitochondrial
membranes. ONOO− has a half-life of about 3–5 ms in mitochondria
and is a strong oxidant of mitochondrial proteins and lipids lying in
close proximity [3]. Thus mitochondria can be both a site for ONOO−
production and a target of ONOO− induced dPTMs [3]. For example,
ONOO− mediates inactivation of mitochondrial manganese superoxide
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dismutase (MnSOD) through nitration and oxidation of critical tyrosine
residues [11,12]. However, the most vulnerable protein sites, the
mechanisms by which ONOO− mediates damage to mitochondria, and
the cardiac functional consequences are not well known.
In general, ONOO− can directly oxidize molecules, decompose to
NO2• and •OH, or react with CO2 to form C𝑂3•− and NO2• [13]. These
free radicals induce protein nitration, especially of exposed tyrosine
(tyr) residues to form 3-nitrotyrosine (3-NT) [6]. Tyrosine nitration
(tyr-N) is an established marker not only for RNS-induced stress
resulting from ONOO− and its radical products, but also for ONOO−
mediated cytotoxicity; once formed, 3-NT is relatively stable and the
nitration can result in deleterious protein structural and functional
changes [3,13]. Tyr-N may itself cause protein dysfunction and it may
also prevent tyr phosphorylation by tyr kinases [14]. Although tyr-N is
widely used as a biological assay indicative of ONOO− generation, it is
acknowledged that ONOO− can also nitrate tryptophan and
phenylalanine and that it also oxidizes other sites, e.g. FeS centers,
protein thiols, and lipids [10]. Moreover, tyr-N may be induced by
ONOO− independent oxidants like the gas NO2• formed by oxidation of
N𝑂2− (itself an oxidized product of NO•) in the presence of H2O2 by
peroxidase, but high concentrations of this labile NO2• product are
likely required to induce tyr-N [15].
Both in vivo and in vitro evidence indicates that proteins
involved in oxidative phosphorylation and apoptosis can be nitrated in
various diseases and disorders [16]. Nitration of proteins has been
observed after IR injury [17–22], but the effect of IR on inducing
irreversible dPTMs that alter the structure and function of key
mitochondrial proteins has not been well examined. Liu et al. [17]
indirectly identified 10 mitochondrial proteins including 4 subunits from
the oxidative phosphorylation system, five enzymes in the matrix, and
the voltage-dependent anion channel (VDAC) that were nitrated after
IR injury using two-dimensional gel electrophoresis (2-DE) gel and
mass spectrometry (MS) analysis. However, the identification of these
tyr-N proteins using specific antibodies, and the determination of the
specific sites of tyr-N by MS have not been undertaken; nor is it known
if nitration of mitochondrial proteins during cardiac IR could be
reduced by ROS/RNS scavenging or by inhibiting nitric oxide synthase
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(NOS), and if identified nitrated mitochondrial proteins exhibit altered
function.
We proposed that some key mitochondrial proteins undergo tyrN during IR injury and that attenuating formation of ONOO− reduces
tyr-N of these proteins and leads to improve cardiac function. Thus our
first objective was to identify specific mitochondrial proteins that
undergo enhanced tyr-N after cardiac IR injury. We identified VDAC as
a tyr-N protein, and so pursued VDAC as a focus for additional studies.
Although other proteins can be nitrated during IR injury, we focused
on VDAC based on our initial results. We probed ONOO− induced tyr-N
of recombinant (r) VDAC and its effect on changing rVDAC channel
activity. In addition we tested if resveratrol (RES, trans-3, 4′, 5trihydroxystilbene), a putative 𝑂2•− and ONOO− scavenger, and NGnitro-L-arginine methyl ester (L-NAME), an unspecific NOS inhibitor,
could reduce the extent of tyr-N in mitochondrial proteins in
association with reduced levels of 𝑂2•− and ONOO− and improve
functional recovery after IR injury in intact hearts. Our focus on the
molecular aspect in this study provides amore mechanistic insight into
how ROS/RNS impacts mitochondrial proteins and leads to the
functional changes in myocardial function during IR. Such an in depth
approach could provide for better strategies to mitigate IR injury.

2. Methods
2.1. Isolated heart preparation and protocols
Hearts in situ cannot be used to detect 𝑂2•− and ONOO−, so
isolated hearts from guinea pigs were utilized to directly correlate
changes in total cardiac oxidative stress and function in isolated
mitochondria after IR injury. Our animal protocols conformed to the
Guide for the Care and Use of Laboratory Animals (National Institutes
of Health No. 85-23, Revised 1996) and were described previously
[4,7,23,24] (see detailed descriptions in the Online Supplement
Materials and Methods). After 30 min of global ischemia, or after 10,
30, or 60 min reperfusion, hearts were removed and mitochondria
were immediately isolated. In the treated groups either 100 µmol/L LNAME or 10 µmol/L RES was perfused for 10 min up to initiation of
global ischemia so that the drug remained in the hearts during
Biochimica et Biophysica Acta: Bioenergetics, Vol. 1817, No. 11 (November 2012): pg. 2049-2059. DOI. This article is ©
Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Elsevier.

5

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

ischemia. RES, 10 µmol/L, is cardioprotective in isolated rat hearts
[25] and 100 µmol/L L-NAME blocks increased ONOO− production in
17°C-perfused isolated hearts [24].

2.2. Detection of 𝑶•𝟐− and ONOO− in isolated hearts
The intracellular fluorescent probe dihydroethidium (DHE)
(Molecular Probes) was used to assess 𝑂2•− emission in isolated hearts
as described previously (see Online Supplement Materials and
Methods) [7,23,24,26]. After attaining stability, hearts were loaded
with 10 µmol/L DHE for 20 min followed by washout of residual DHE
for another 20 min. Dityrosine (DiTyr) was used to detect ONOO−
formation indirectly as described previously (see Online Supplement
Materials and Methods) [24]. ONOO− reacts with continuously perfused
L-tyrosine (0.3 mmol/L) to form the fluorescent dimer DiTyr [9], a
stable product at tissue pH [27]. DHE loaded/L-tyrosine perfused
hearts were treated with/without RES/L-NAME before ischemia,
followed by IR.

2.3. Isolation of mitochondria
Cardiac mitochondria were isolated at the end of each functional
study using well-established methods in our laboratory [28–30] with
minor modifications. All isolation procedures were carried out at 4 °C.
Hearts were minced into very small pieces in a chilled isolation buffer
containing 200 mmol/L mannitol, 50 mmol/L sucrose, 5 mmol/L
KH2PO4, 5 mmol/L MOPS, 0.1% fatty acid free bovine serum albumin
(BSA) and 1 mmol/L EGTA, at pH 7.15, then homogenized in 2.65 ml
isolation buffer containing protease (5 U/ml, Sigma Cat: P-5495) for
15 s with an ultrasonic homogenizer. After this, 15 ml of isolation
buffer containing protease inhibitors (Roche, Complete protease
inhibitor cocktail tablets) was added rapidly to the homogenate
followed by another 15 s of homogenization. The slurried homogenates
were centrifuged at 10,000 g for 5 min, and then the pellet was
resuspended in isolation buffer containing protease inhibitors and
centrifuged at 8000 g for another 10 min. After that, the pellet was
resuspended in isolation buffer containing protease inhibitors and spun
at 750 g for 10 min; then the supernatant was collected and
centrifuged again at 8000 g. The resulting mitochondrial pellet was
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resuspended in isolation buffer containing protease inhibitors and
stored at −80 °C for later use. The amount of mitochondrial protein
was assessed using Bio-Rad protein assay with BSA as the standard.

2.4. Immunoprecipitation of mitochondrial proteins
Immunoprecipitation (IP)was performed as described before
[17,31] with minor changes. Mitochondria were pelleted and then
lysed in RIPA buffer containing 50 mmol/L Tris-Cl pH 7.4, 150 mmol/L
NaCl, 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS and
protease inhibitors on ice for 30 min. The sample was pre-cleared with
30 µl protein G Sepharose-4B beads (Invitrogen) for 1h at 4°C with
constant end-over-end shaking and then centrifuged at 3000 g for 5
min. The supernatant was collected, adjusted to 2 mg/ml protein
concentration with RIPA buffer containing protease inhibitors, and
subjected to IP with an anti-3-nitrotyrosine monoclonal antibody (anti3-NT, Millipore) or anti-VDAC antibody (Sigma) at 4 °C with constant
end-over-end shaking overnight. The next day, after adding 30 µl
protein G Sepharose-4B beads, the mixture was incubated for another
2 h under the same conditions as above. The beads were collected and
exhaustively washed (five times) with RIPA buffer. The final pellet was
re-suspended in 50 µl sample buffer containing 50 mmol/L Tris-Cl,
10% glycerol, 500 mmol/L β-mercaptoethanol, 2% SDS, 0.01% w/v
bromophenol blue and protease inhibitors at pH 7.4 and boiled at
95 °C for 5 min. The immunoprecipitated proteins were separated
using SDS-PAGE. The gels were silver stained or subjected to Western
blot analysis.

2.5. Two-dimensional gel electrophoresis (2-DE)
2-DE was performed with the IEF/Criterion gel system (BioRad). Mitochondrial pellets were lysed in lysis buffer containing 7.8
mol/L urea, 2.2 mol/L thiourea, 4% CHAPS, and protease inhibitors on
ice for 30 min, then desalted twice with Amicon 3 kDa (Millipore). After
adding 65 mmol/L DTT and 1% Bio-Lyte ampholyte (pH3-10), about
800 µg of protein from each sample was immediately loaded onto an
11-cm nonlinear pH 3–10 IPG strip (Bio-Rad). The strips were
rehydrated at 50 V for 12 h and then focused under the following
conditions: voltage was first increased to 250 V over 20 min followed
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by a linear increase to 8000 V over 70 min and then held at 8000 V
until 26 kVh was attained. The focused IPG strips were then
equilibrated for 15 min in 0.375 mol/L Tris-Cl, pH 8.8, 6 mol/L urea,
20% glycerol, 2% SDS and 2% DTT followed by 15 min in 0.375 mol/L
Tris-Cl, pH 8.8, 6 mol/L urea, 20% glycerol, 2% SDS and 2.5%
iodoacetamide. The equilibrated strips were loaded on pre-cast gels
(Criterion™10%, 11 cm; Bio-Rad) for the second dimension
separation. The gels were run at 150 V for 70 min and then
transferred onto polyvinylidene difluoride (PVDF) membranes for
Western blot analysis with anti-VDAC and anti-3-NT antibodies.

2.6. Western blot analysis
Mitochondrial pellets were lysed in sample buffer and boiled at
95 °C for 5 min. Mitochondrial samples (100 µg) or
immunoprecipitates were resolved by SDS-PAGE and transferred onto
PVDF membranes. Membranes were incubated with specific primary
antibodies against 3-NT, VDAC (Cell Signaling), and ANT (adenine
nucleotide translocator, Santa Cruz). Washed membranes were
incubated with the appropriate secondary antibody conjugated to
horseradish peroxidase, then immersed in an enhanced
chemiluminescence detection solution (GE Healthcare) and exposed to
X-Ray film for autoradiography. For monitoring loaded protein
amounts, VDAC or ANT protein was used as loading controls because
VDAC and/or ANT are mitochondrial membrane proteins and their
detection confirms mitochondrial isolation. Blots were stripped with
buffer (62.5 mmol/L Tris-Cl, 2% SDS, and 100 mmol/L βmercaptoethanol at pH 6.8), and then probed with specific antibodies
against VDAC or ANT.

2.7. In-gel tryptic digestion of protein bands
Protein bands from silver-stained gels were excised and cut into
small pieces and then subjected to in-gel digestion by trypsin as
described by Newman et al. [32]. In brief, after destaining silver ions
with a 1:1 solution of 100 mmol/L Na2S2O3 and 30 mmol/L K3Fe9(CN)6,
the gel pieces were dehydrated with 50% acetonitrile and then 25
mmol/L (NH4)HCO3/50% acetonitrile (pH 8.0). The dehydrated gel
pieces were dried and then digested with 40 ng trypsin in 100 µl of 25
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mmol/L (NH4)HCO3 (pH 8.0) overnight at 37 °C. Tryptic fragments
were extracted from gel slices with acetonitrile/trifluoroacetic acid
(TFA)/water (70:0.1:29.9 v/v/v). Extracted samples were dried and
prepared either for LC–MS/MS or MALDI-TOF MS analysis.

2.8. Protein identification by LC–MS/MS mass
spectrometry
Extracted tryptic fragments were subjected to LC–MS/MS
analysis using a LTQ (Thermo-Fisher) MS coupled to a Surveyor HPLC
system equipped with a Micro AS auto sampler. Separation of tryptic
peptides was achieved online before MS/MS analysis on an Aquasil,
C18 PicoFrit capillary column (75 mm × 100 mm; New Objective) with
the following conditions: mobile phase A, 0.1% formic acid containing
5% acetonitrile; and mobile phase B, 0.1% formic acid in 95%
acetonitrile, respectively. A 180 min linear gradient was applied. The
ions eluted from the column were electro-sprayed at a voltage of 1.75
kV. MS/MS spectra data were analyzed using the SEQUEST search
engine and analysis carried out via the Visualize software program
[33]. The SEQUEST search parameters were set with no fixed
modification, one missed trypsin cleavage site, a peptide tolerance of
1.2 Da, and a MS/MS tolerance of 0.8 Da, and then searched against
the rodent subset of the Uniprot database. All proteins identified had
to meet a False Discovery Rate (FDR) of 1.5% or less.

2.9. Protein identification by MALDI-TOF mass
spectrometry
MALDI-TOF MS was also performed as described by Newman et
al. [32]. Briefly, the dried extracted samples were resuspended in 20
µl 0.1% TFA and subjected to purification using Micro-C18 Zip-Tips
(Millipore). The purified samples were eluted in 1–2 µl volume of αcyano-4-hydroxycinnamic acid in 60% acetonitrile/0.1% TFA and then
directly loaded on the sample plate for analysis using a Voyager DE
PRO MALDI-TOF mass spectrometer in positive ion, reflector, delayedextraction mode (Applied Biosystems). Peptide masses were analyzed
using the Protein Prospector software
(http://prospector.ucsf.edu/prospector/mshome.html).
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2.10. Nitration of recombinant VDAC induced by
exogenous ONOO− in vitro
Because VDAC was identified as a key tyr-N protein after cardiac
IR injury, we further explored for specific VDAC tyr-N residues and
determined if tyr-N of VDAC affects its structure and function. To do so
we exposed recombinant VDAC (rVDAC) to different concentrations of
exogenous ONOO− to induce concentration-dependent nitration of
rVDAC in vitro. Rat VDAC-1 full-length cDNA (GenBank: BC072484,
purchased from Open Biosystems) was cloned into pET-21a vector
(Novagen) and expressed in BL21 cells. rVDAC proteins were extracted
with BugBuster Master Mix (Novagen) and purified with Ni-NTA
His·Bind Resins (Novagen). Purified rVDAC was refolded at 4 °C by
dropwise dilution of one volume protein with 10 volumes refolding
buffer containing 20 mmol/L Tris-Cl, 100 mmol/L NaCl, 1%
lauryldimethylamineoxide (LDAO), and 1 mmol/L DTT at pH 7.4
[34,35]. It has been reported that using the detergent LDAO resulted
in a 90% refolding of rVDAC compared to 75% and 30% for the
detergents DDM or C8E4, respectively [35]. After refolding, the
refolded rVDAC protein was dialyzed against refolding buffer, without
DTT, at 4 °C to remove the DTT. The reconstituted rVDAC was used
for in vitro nitration by ONOO−. ONOO− (Calbiochem) concentration
was determined by absorbance at 302 nm with an extinction
coefficient of 1670 M−1 cm−1 in 100 mmol/L of NaOH prior to use [36].
For exposure of rVDAC to ONOO−, 500 µg of rVDAC at 3 mg/ml was
incubated with 0–400 µmol/L ONOO− at 23 °C for 30 min. The ONOO−treated rVDAC was subjected to SDS-PAGE or 2-DE, followed by
Western blot with antibodies against 3-NT and VDAC, or gels were
stained with silver staining and VDAC bands were cut for MALDI-TOF
MS.

2.11. Reconstitution of rVDAC into planar lipid bilayers
for channel activity
Channel activity of rVDAC was monitored by incorporating
rVDAC into planar lipid bilayers (PLB), as previously described [37].
Briefly, phospholipids were prepared by mixing
phosphatidylethanolamine, phosphatidylserine and phosphatidylcholine
(Avanti Polar Lipids, Alabaster, AL) in a ratio of 5:4:1 (v/v); the
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phospholipids were dried under N2 and re-suspended in n-decane to a
final concentration of 25 mg/ml. The cis/trans chambers contained
identical solutions of 10 mmol/L HEPES, 500 mmol/L NaCl and 1
mmol/L CaCl2 at pH 7.4. The cis chamber was held at virtual ground
and the trans chamber was held at the command voltages. rVDAC
protein was added into the cis chamber. After channel incorporation
into the bilayer, ONOO− was added to the cis chamber and diluted
proportionally to achieve the desired concentration of 50 µmol/L.
Currents were sampled at 5 kHz and low pass filtered at 1 kHz using a
voltage clamp amplifier (Axopatch 200B, Molecular Devices) connected
to a digitizer (DigiData 1440, Molecular Devices), and recorded in 1
min segments. The pClamp software (version 10, Molecular Devices)
was used for data acquisition and analysis. Additional analyses were
conducted using Origin 7.5 (OriginLab).

2.12. Statistical analysis
All results are expressed as means ± SEM and were analyzed by
one-way ANOVA followed by a post-hoc analysis (Student–Newman–
Keuls' test) to determined statistically significant differences of means
among groups. A value of p < 0.05 was considered significant (twotailed).

3. Results
3.1. 𝑶•𝟐− and ONOO− production increase in isolated
hearts during IR injury
DHE fluorescence (𝑂2•− emission) increased during ischemia; on
reperfusion, it declined abruptly, but remained higher than baseline
values (Fig. 1A, IR10), consistent with our previous findings [7,23,26].
Similarly, DiTyr fluorescence (ONOO−) increased and remained
elevated during ischemia; on reperfusion it decreased to baseline
levels (Fig. 1B, IR10). Time control (TC) groups showed no significant
changes in DHE (𝑂2•− ) and DiTry (ONOO−) fluorescence during the
duration of the perfusion protocol (Fig. 1A and B, TC).
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Fig. 1

Time course of changes in superoxide (𝑂2•− ) and peroxynitrite (ONOO−)

levels during IR. A: The fluorescence probe DHE, via its stable (ethidium) or unstable
and labile 2-hydoxyethidium (2-OH-E+) product was used to assess intracellular
𝑂2•− emission online in isolated hearts at the LV free wall. B: Dityrosine (DiTyr)
fluorescence formed from L-tyrosine in the presence of ONOO− was used to monitor
ONOO− online similar to that described for the DHE fluorescence probe. TC: Time
control; IR10: 30 min ischemia and 10 min reperfusion; N = 4–5 hearts/group/probe;
Values are mean ± SEM. *: p < 0.05 vs. TC. See Table 1 for functional data.

These changes in 𝑂2•− and ONOO− generation also correlated
with the changes of function in isolated hearts. Systolic–diastolic left
ventricular pressure (dLVP), indices of contractility and relaxation
(dLVP/dtmax and dLVP/dtmin) respectively decreased, while diastolic LVP
increased during ischemia (Table 1, IR10, IR60); during reperfusion,
dLVP/dtmax, dLVP/dtmin and dLVP recovered to almost half the preBiochimica et Biophysica Acta: Bioenergetics, Vol. 1817, No. 11 (November 2012): pg. 2049-2059. DOI. This article is ©
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ischemia values while diastolic LVP remained significantly higher than
the pre-ischemia level (Table 1, IR10, IR60). Cardiac function was
unchanged over time in the TC groups (see Online Supplement Table
S3). Heart rate was unchanged on reperfusion compared to preischemia in all groups (Table 1).

3.2. Mitochondrial protein tyr-N increases after cardiac
IR injury
The isolated heart experiments strongly implicated the potential
for cardiac protein tyr-N, as a marker of ONOO−-induced dPTMs.
Because mitochondrial dysfunction plays a key role in IR injury, we
assessed concurrently the extent of mitochondrial protein tyr-N.
Mitochondria isolated from TC, I30, IR10, IR30 and IR60 groups were
subjected to Western blotting with anti-3-NT antibody. Several
immunoreactive bands were detected in all groups (Fig. 2A).
Compared to TC, IR caused an increase in anti-3-NT band signal
intensity at 35 kDa and 15 kDa. To exclude the possibility that
stronger anti-3-NT signals were derived from large amounts of protein
loaded, we chose ANT (~35 kDa) protein as the loading control, which
was similar in all groups (Fig. 2A). Comparison of the ratio of densities
of anti-3-NT bands to anti-ANT bands DHE fluorescence (afu) among
all groups (Fig. 2B) clearly confirmed that enhanced anti-3-NT
immunoreaction occurred in the IR groups.
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Table 1

Cardiac function in IR10, 60, resveratrol and L-NAME treated IR10 groups

during baseline, ischemia 30 min and reperfusion 10 and 60 min.

IR10: 30 min of ischemia and 10 min of reperfusion; IR60 only in non-treated group;
sys–dia LVP, systolic–diastolic left ventricular pressure; dLVP/dtmax, index of
contractility; dLVP/dtmin: index of relaxation; N = 8–10 hearts/group. Values are
mean ± SEM. *p < 0.05: IR10 + RES, IR10 + L-NAME vs. IR10, 60.
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Fig. 2

Assessment of tyr-N of mitochondrial proteins isolated from hearts and

identity of tyr-N mitochondrial proteins. A: Assessment of tyr-N of cardiac
mitochondrial proteins from TC and IR groups hearts by Western blot with anti-3-NT
antibody. Amounts of loaded mitochondrial proteins were monitored with anti-ANT
antibody. B: Densitometric analysis of Western blot of tyr-N of mitochondrial proteins.
The densities of anti-3-NT bands at about 35 kDa and 15 kDa, and ANT bands were
measured using ImageJ system, after which % density of each anti-3-NT bands was
normalized to % density of their corresponding ANT bands. A is a representative blot
and B is the mean ± SEM of four experiments. *: p < 0.05 vs. TC group. TC: time
control; I: Ischemia; R: Reperfusion. MW: molecular weight. C: Mitochondrial proteins
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isolated from IR groups were subjected to IP with anti-3-NT antibody followed by
Western blots with indicated antibodies. Lanes 1 and 3: total mitochondrial protein
lysates (input); lanes 2 and 4: IP with anti-3-NT antibody. MW: molecular weight; WB:
Western blot. D: VDAC from mitochondrial protein of TC and IR10 groups was first
individually immunoprecipitated with anti-VDAC antibody. The immunoprecipitates
were subjected to Western blotting with anti-3-NT antibody and then the membrane
was stripped and reblotted with anti-VDAC antibody. E: Densities of anti-3-NT bands
and VDAC bands in TC and IR10 groups were measured using ImageJ system, after
which % density of each anti-3-NT bands was normalized to % density of their
corresponding VDAC bands. WB: Western blot. D is a representative blot and E is the
mean ± SEM of three experiments. *: p < 0.05 IR10 vs. TC.

3.3. Identity of tyr-N mitochondrial proteins with
specific antibodies and mass spectrometry
To identify the enhanced tyr-N proteins implicated by the
Western blot above (Fig. 2A), we subjected the total mitochondrial
protein extracts from IR groups to IP with an anti-3-NT antibody. After
IP, the immunoprecipitates were subjected to SDS-PAGE to remove
the detergent and collect sample for LC–MS/MS assay. After the
immunoprecipitates entered the separating gel part of the SDS-PAGE
gel from loading wells, the gel was run for 5 min and then silver
stained. The silver stained protein areas on the gel that include all
sizes of proteins were collected and cut into two parts for LC–MS/MS
(Fig. S1 lane 1, Online Supplement). Initially, 13 mitochondrial
proteins were obtained from immunoprecipitates of the anti-3-NT
(Table S1, Online Supplement). Four of these were polypeptides from
the ETC and five were components of the TCA cycle. Notably, two
proteins, VDAC and ANT, with molecular weights of about 35 kDa,
which are similar to the above Western blot 35 kDa tyr-N protein band
size (Fig. 2A), were also obtained. This indicated that these two
proteins might be candidates of tyr-N mitochondrial proteins.
We used protein specific antibodies to further identity tyr-N
proteins displayed on the Western blots. Based on molecular weights
of the candidate proteins listed in Online Supplement Table S1 and on
Western blot analyses (Fig. 2A), we focused on identifying whether
ANT and/or VDAC was the 35 kDa tyr-N protein. IP assays of
mitochondrial protein extracts of IR groups were carried out with anti3-NT antibody followed by Western blotting with antibodies against
VDAC and ANT. Immunoreactive signals were detected when the VDAC
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antibody was used to probe anti-3-NT immunoprecipitates (Fig. 2C,
Lane 4). This corresponded to a similar size 35 kDa band in the total
mitochondrial protein lysate probed with anti-VDAC antibody (Fig. 2C,
Lane 3, input) or probed with anti-3-NT antibody (Fig. 2A). In
contrast, when ANT antibody (Fig. 2C, Lane 2) was used no
immunoreactive signal was detected from the anti-3-NT
immunoprecipitates. These data strongly implicated VDAC as the 35
kDa protein exhibiting enhanced tyr-N after IR injury. A 15 kDa
mitochondrial protein also displayed enhanced tyr-N in IR groups on
Western blot and we also found 3 proteins with molecular weights
about 15 kDa (see Online Supplement Table S1); identity of these tyrN proteins is as yet incomplete; our intent here was to focus only on
VDAC.
Next we utilized an approach reported by Tran et al. [38] to
compare the relative ratio of nitrated VDAC to total VDAC between the
TC and IR groups. Based on Fig. 2A results, at the 35 kDa protein, the
IR10 group displayed a similar tyr-N level as the IR60 group, but
higher than the IR30 group. Therefore, we chose the IR10 group to
compare with the TC in this and all other experiments. Mitochondria
were isolated as described in Method (see Method 2.3) from TC and
IR10 hearts. VDAC was first immunoprecipitated with anti-VDAC
antibody (Sigma) from mitochondrial protein lysate of TC and IR10
groups individually. The immunoprecipitates were subjected to
Western blotting with anti-3-NT antibody, and then the membranes
were stripped and reblotted with anti-VDAC antibody (Cell Signaling).
The resulting Western blots showed that similar amounts of VDAC
protein were immunoprecipitated from the TC and IR10 groups (Fig.
2D, bottom panel), whereas immunoprecipitated tyr-N VDAC increased
in the IR10 group compared to the TC group (Fig. 2D, upper panel).
Comparison of the relative ratio of the tyr-N VDAC bands to the total
VDAC bands clearly confirmed that IR increased VDAC nitration
significantly by approximately 4 fold (Fig. 2E). This result (Fig. 2D, E)
was similar to the result of Western blotting with anti-3-NT shown in
Fig. 2A and B, which displayed a 35 kDa protein (identified as VDAC)
with a higher tyr-N level in the IR than in the TC group.
To further confirm tyr-N of VADC, mitochondrial proteins from
TC and IR10 groups were subjected to 2-DE individually, followed by
Western blots with anti-3-NT antibody. After blotting with anti-3-NT
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antibody, the membranes were stripped and then reblotted with antiVDAC antibody. The results showed that VDAC spots (solid tilted
arrows) displayed strong immunoreactivity to anti-3-NT antibody in
the IR10 group (Fig. S2B, D, Online Supplement), whereas in the TC
group, the VDAC spot (dotted tilted arrows) showed only a slight
immunoreactive signal with anti-3-NT antibody (Fig. S2A, C, Online
Supplement). Why two VDAC spots showed immunoreactivity to anti3-NT antibody (solid tilted arrows, Fig. S2, Online Supplement) in the
IR10 group is unclear at this time.

3.4. ONOO− induces tyr-N of rVDAC in vitro
The aim of these experiments was to identify specific tyr-N
residues and further confirm tyr-N of VDAC. Purified rVDAC was
exposed to ONOO− (0–400 µmol/L) and the ONOO−-treated rVDAC
protein was subjected to Western blotting with anti-3-NT antibody. Our
approach showed that rVDAC can be nitrated by as low as 10 µmol/L
of ONOO− (Fig. 3A); moreover, signal intensity of tyr-N of rVDAC
increased as [ONOO−] increased. Some tyr-N of rVDAC protein
exhibited slow mobility on the SDS-PAGE gel. In addition to the 35
kDa bands (rVDAC monomer), additional bands with molecular weights
of approximately 65 kDa, 100 kDa, and higher appeared. This
indicated formation of higher molecular mass species (Fig. 3A) and
suggested that tyr-N induced a structural alteration of rVDAC that led
to protein oligomerization.
In addition, we examined the characteristics of rVDAC incubated
with ONOO− by 2-DE. In this experiment, we chose one concentration
of ONOO−, i.e. 200 µmol/L, to treat rVDAC. After treatment rVDAC
appeared as 4 adjacent spots (Fig. S3B and D, Online Supplement);
three of these spots revealed equal signal intensities to anti-3-NT
antibody and to anti-VDAC antibody, whereas most of the control
(non-nitrated) rVDAC were accumulated at two adjacent spots and
showed no immunoreactivity to anti-3-NT antibody (Fig. S3A and C,
Online Supplement).
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Fig. 3.

Tyr-N of recombinant (r) VDAC induced by ONOO−in vitro. A: rVDAC was

incubated with 0–400 μmol/L ONOO− and subjected to Western blot with anti-3-NT
antibody. rVDAC loading was monitored with anti-VDAC antibody. B: Mass
spectrometric characterization of the peptide fragment 62YRWTEYGLTFTEK74
determined by MALDI-TOF MS. Peaks labeled at m/z 1693 correspond to the peptide
containing an unmodified tyr residue and peaks labeled at m/z 1738 correspond to the
same peptide as m/z 1693, but with a tyr-N residue, i.e. one that displays a + 45
mass unit shift. MW: molecular weight

To identify possible tyr-N residues in the rVDAC, we excised
ONOO -untreated (0 µmol/L) and 100, 200, 400 µmol/L ONOO−treated rVDAC bands on silver stained SDS-PAGE gels, and then
subjected them to MALDI-TOF MS. The sensitivity of the MALDI-TOF
MS assay is lower than that of the Western blots, because in the MS
−
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analysis only 1–2 µl of trypsin-digested sample was loaded on the
sample plate, and the laser beam hits peptide fragments partially and
randomly. Therefore, for this experiment 100, 200, 400 µmol/L of
ONOO− was used to treat rVDAC. Nine of 11 total tyr residues (Y) of
rVDAC were detected by MALDI-TOF MS, specifically, 22Y, 62Y, 67Y, 146Y,
153
Y, 173Y, 195Y, 225Y and 247Y (Online Supplement Table S2). Among the
identified Y-containing peptide fragments, one fragment,
62
YRWTEYGLTFTEK74, displayed a +45 mass units' shift from m/z 1693
to 1738 in ONOO−-treated rVDAC (Fig. 3B), consistent with a single
NO2 group added to either 62Y or 67Y. In ONOO−-untreated (control)
rVDAC, the intensity of spectrum m/z 1693 was highest among all four
groups, while the spectrumm/z 1738 was absent. In ONOO−-treated
rVDAC, the intensity of spectra m/z 1693 decreased gradually with
increasing [ONOO−], while spectra m/z 1738 appeared among the
three ONOO−-treated rVDAC groups (Fig. 3B). The site(s) identified in
ONOO−-treated rVDAC may or may not be the same as in native VDAC
after IR injury.

3.5. Resveratrol or L-NAME treatments reduce
mitochondrial protein tyr-N
We next examined if the enhanced protein tyr-N during IR is
attributable to the increases in ONOO− formation resulting from
combined generation of NO• and 𝑂2•− . Hearts were treated with LNAME or RES before 30 min ischemia, followed by IR, and tyr-N of
mitochondrial proteins was again evaluated as described above (see
Results 3.2) by Western blot with anti-3-NT antibody. Both RES and LNAME reduced tyr-N of 35 kDa (identified as VDAC) and 15 kDa
mitochondrial proteins compared to the untreated group (Fig. 4A, B).
These data indicated that ONOO− produced during IR injury induced
mitochondrial protein nitration, in particular tyr-N of VDAC.
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Fig. 4

Inhibitory effects of L-NAME and resveratrol (RES) on mitochondrial protein

tyr-N. A: Isolated hearts were treated without or with L-NAME (100 μmol/L) or RES
(10 μmol/L) for 10 min before the onset of ischemia. After reperfusion, mitochondria
were isolated and tyr-N of mitochondrial protein was evaluated by Western blot with
an anti-3-NT antibody. The amount of mitochondrial protein loaded was assessed by
reprobing the membrane with anti-ANT (A, lower panel). B: Densities of anti-3-NT
bands at about 35 kDa, 15 kDa and ANT bands were measured using the ImageJ
system, and then density of each anti-3-NT bands was normalized to their
corresponding ANT band. A is a representative blot and B is means ± SEM of all
experiments performed in triplicates. #: p < 0.05, compared to IR10.

To correlate the preventive effects of L-NAME and RES on
mitochondrial protein tyr-N with cardioprotection during IR injury, we
monitored ONOO− and 𝑂2•− production online in isolated hearts. L-NAME
attenuated DiTyr fluorescence (ONOO−) levels during ischemia (Fig.
5B). We showed previously that L-NAME reduced cold-induced ONOO−
production, but that it did not alter 𝑂2•− emission [24]. Because RES
interfered with the DiTyr fluorescence signal, we could only monitor
the 𝑂2•− emission with DHE fluorescence. RES attenuated DHE
fluorescence (𝑂2•− emission) induced during ischemia and completely
blocked it during reperfusion (Fig. 5A). Reduction of DiTyr/DHE
Biochimica et Biophysica Acta: Bioenergetics, Vol. 1817, No. 11 (November 2012): pg. 2049-2059. DOI. This article is ©
Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Elsevier.

21

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

fluorescence by L-NAME and RES was associated with a significant
improvement in cardiac function during reperfusion (Table 1).
Collectively, reducing ONOO−/𝑂2•− production during IR decreased
protein tyr-N, and at the same time improved recovery of function on
reperfusion.

Fig. 5

Effects of L-NAME and resveratrol on 𝑂2•− and ONOO− production in isolated

hearts. Levels of 𝑂2•− and ONOO− were measured online with DHE (A) and L-tyrosine
(B), respectively, as described in section 2. DHE/DiTyr fluorescence intensities in
arbitrary fluorescence units (afu) were normalized to zero at baseline. *: p < 0.05,
compared to IR10 + RES/L-NAME. TC: time control; IR10: Ischemia 30 min,
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reperfusion 10 min; RES: resveratrol; L-NAME: NG-nitro-L-arginine methyl ester; MW:
molecular weight.

3.6. Resveratrol reduces rVDAC tyr-N in vitro
To verify that L-NAME and RES attenuated VDAC tyr-N during
IR, rVDAC was incubated with ONOO− (0–100 µmol/L), with or without
RES or L-NAME; rVDAC tyr-N was evaluated again by Western blot
using anti-3-NT antibody. Incubation with ONOO− resulted in tyr-N of
rVDAC (Fig. 6A). RES, 100 µmol/L, abolished tyr-N of rVDAC, while LNAME (100 µmol/L) had no effect. The inhibitory effect of RES on
ONOO− induced rVDAC tyr-N was concentration-dependent, such that
greater than 10 µmol/L RES inhibited rVDAC tyr-N induced by 20
µmol/L of ONOO− (Fig. 6B). This suggests that L-NAME inhibits only
generation of NO• in the presence of NOS, whereas RES scavenges
both 𝑂2•− and ONOO−.

Fig. 6

Inhibition of recombinant (rVDAC) tyr-N by L-NAME and resveratrol (RES) in

vitro. A: rVDAC was incubated with ONOO− (0–100 μmol/L), with or without L-NAME
(100 μmol/L) or RES (100 μmol/L), and subjected to Western blot with an anti-3-NT
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antibody. rVDAC loading was monitored with VDAC antibody. B: Western blot analysis
of rVDAC incubated with 20 μmol/L of ONOO− without or with 5–100 μmol/L RES with
anti-3-NT antibody. Values are mean ± SEM of three experiments. *: p < 0.05 vs.
non-treated VDAC.

3.7. ONOO− enhances rVDAC conductance
We next investigated if ONOO− altered rVDAC activity by
recording single channel conductance after reconstituting rVDAC into
PLB. We assumed that ONOO− is the major species inducing tyr-N of
rVDAC. rVDAC exhibited a characteristic voltage-dependent
conductance (Fig. 7A), which is similar to native VDAC (Fig. S4, right
panel, Online Supplement) [37]. The effect of ONOO− on rVDAC was
monitored at a membrane potential of −10 mV. Under control
conditions, primary rVDAC chord conductance was approximately 1.8
nS as depicted by the unitary current amplitude of 18 pA (Fig. 7B).
When 50 µmol/L ONOO− was added, channel activity was enhanced
with multiple higher conductance states, as evidenced by current
amplitudes of −25 pA and −30 pA (Fig. 7B). These experiments
demonstrate that 50 µmol/L ONOO− directly enhanced rVDAC
conductance.
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Fig. 7 Effects of ONOO− on recombinant (r) VDAC channel activity. A:
Characteristic voltage-dependence of rVDAC in response to a ramp
voltage protocol from − 80 to + 80 mV under control conditions. B:
Effects of adding ONOO− on rVDAC activity. Current traces show in
control and after adding 50 μmol/L ONOO− obtained at a membrane
potential of − 10 mV. In control, primary conductance was 1.8 nS.
Application of ONOO− triggered enhanced opening of VDAC as
evidenced by the multiple conductance states. Corresponding allpoints amplitude histograms are also shown.

4. Discussion
The functional and biological consequences of tyr-N depend on
which proteins are nitrated as well as on the extent and sites of
nitration in a given protein [39]. Identifying tyr-N of mitochondrial
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proteins should help to define the potential pathogenic role of this
dPTM in disease states and to provide guidance on how and where to
target therapies against these dPTMs. Although there are prior reports
[8,17] that IR injury induces tyr-N of mitochondrial proteins, only a
few proteins so far have been identified, and there has been no direct
evidence for VDAC nitration or for specifically nitrated tyr residues.
Here we used proteomic analyses and IP assays to search for specific
proteins that undergo enhanced tyr-N during IR in isolated perfused
hearts. We found that VDAC, a key and abundant outer mitochondrial
membrane (OMM) protein was targeted for tyr-N during IR. Consistent
with our isolated heart results, the in vitro experiments confirmed that
rVDAC can be nitrated by ONOO− at either the 62Y or 67Y site. In
addition, our results indicate that rVDAC tyr-N may trigger
oligomerization of rVDAC and that ONOO− enhances rVDAC channel
conductance. Thus, nitration of VDAC likely induces alterations in both
its structure and function.
To further explore mechanisms of tyr-N induction, RES or LNAME was perfused into isolated hearts before ischemia as well as
applied to rVDAC protein. In isolated hearts, both RES and L-NAME
decreased VDAC tyr-N, inhibited formation of ONOO−, and improved
cardiac function after IR. In vitro, RES, but not L-NAME, directly
prevented tyr-N of rVDAC induced by ONOO−. Lastly, in vitro tyr-N of
rVDAC confirmed our ex vivo results that RES indeed can scavenge
ONOO− to reduce tyr-N. Overall, our study suggests that VDAC tyr-N
occurs during IR injury and that scavenging O∙−2/ONOO− and
attenuating NO• generation reduces tyr-N of VDAC during IR.

4.1. Sites of VDAC tyr-N and functional change
Previous studies suggested that VDAC tyr-N can occur in mouse
hearts during IR injury [17], in old-aged rat hearts [31], and in rat
hippocampal tissue after acute smoke inhalation [40]. In those
studies, VDAC was suggested as a nitrated protein based on MS
analysis for anti-3-NT positive protein spots on 2-DE gels or anti-3-NT
IP protein mixtures. However, there was no direct evidence of VDAC
tyr-N or of attenuated VDAC tyr-N by inhibitors/scavengers of ONOO−.
Moreover, the impact of tyr-N on rVDAC channel conductance was
unknown. Based on our multifaceted approaches involving MS
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analysis, IP, and electrophysiology, we provide firm evidence that
VDAC tyr-N occurs during cardiac IR injury. Moreover, tyr-N appears
to oligomerize rVDAC and ONOO− increases the rVDAC channel
conductance state. We also newly report that partial prevention of
VDAC tyr-N is associated with improved cardiac function.
Protein tyr-N is a selective process, in so far as not all proteins
can be nitrated. The potential for a protein to become nitrated is
affected by the cellular and subcellular localization of a given protein
[41]. Most nitrating agents are short-lived [42,43], so proteins to be
nitrated must lie in close proximity to the site of ONOO− formation.
Because NO• is a diffusible molecule and 𝑂2•− is diffusion limited and
generated primarily in mitochondria, ONOO− is most likely formed in
mitochondria. As the most abundant protein in the OMM, VDAC is
likely highly exposed to ONOO−. Thus it is probable that VDAC is an
easy target during IR injury for attack by ONOO− with subsequent tyrN.
We examined for a direct functional impact of ONOO− on VDAC
by treating rVDAC incorporated into PLB with ONOO− and found that
50 µmol/L ONOO− enhanced rVDAC channel activity, as shown as
multiple higher conductance states. This may allow increased transport
of metabolites across a “leakier” OMM. It is possible that the higher
conductance states permit release of cytochrome c across the OMM via
VDAC, independent of mitochondrial permeability transition pore
(mPTP). How ONOO− enhances VDAC channel conductance is unclear.
Despite our finding that ONOO− induced higher rVDAC channel
conductance states, it is not established if higher or lower VDAC
channel conductance states contribute to impaired mitochondrial
function during cardiac IR injury. We reported recently a
concentration-dependent, biphasic inhibitory effect of exogenous NO•
on cardiac VDAC [37]. Peak inhibition occurred at a physiologically
relevant level of NO•, and this correlated with a delay in mitochondrial
permeability transition pore (mPTP) opening. Consequently, a NO•induced delay in mPTP opening, in tandem with an induced low
conducting state of VDAC, could potentially contribute to myocardial
protection. This would then support our hypothesis that the ONOO−induced high conductance state of VDAC is detrimental to cardiac
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function, whereas the putatively protective NO•-induced low
conductance state is beneficial.
It is likely that ONOO−-induced VDAC tyr-N leads to structural
alterations because tyr-N renders the neutral tyr residue a charged
residue; this could alter the tertiary structure of VDAC. Indeed, we
found that nitration of rVDAC caused it to oligomerize into dimers or
trimers (Figs. 3, ,6).6). Keinan [44] reported that oligomerization of
VDAC1 was associated with cytochrome c release and apoptosis
induced by various stimuli in many cell types. Although we did not
show directly that VDAC tyr-N is associated with cell death, our recent
data indicate that IR-induced release of cytochrome c [45] occurs at
the same time as tyr-N of mitochondrial proteins (and in particular,
VDAC based on our current study). Thus our study suggests that VDAC
tyr-N may be associated with mitochondrial-mediated cell death.
A rVDAC residue that is a target of nitration was narrowed to
either Y or 67Y. The specific tyr residues capable of tyr-N are
determined by both the protein's structure and the local environment
around the tyr (Y) residues [41]. Most tyr-N residues have been found
in loop structures in the vicinity of turn-inducing amino acids such as
proline or glycine [41,46]. The proximity of negatively charge
residues, such as glutamic or aspartic acids, also benefits nitration of
tyr [41,46]. In our tyr-N containing peptide sequence, 67Y is adjacent
to the turn-inducing residue glycine and the negatively charge residue
glutamic acid, which conforms well to common features of structural
determinants of protein tyr-N. In addition, based on elucidation of the
three-dimensional structure of VDAC, 67Y is located in the loop region
between the β3 and β4 strands [47]. Consequently, 67Y is likely the
nitrated residue in the rVDAC, but for now nitration of 62Y cannot be
excluded.
62

4.2. Reduced mitochondrial protein tyr-N occurs with
improved recovery after IR injury
There is now ample evidence that RNS/ROS-induced protein tyrN is a critical factor underlying cardiac IR injury [19,48]. Inhibiting
NOS activity reduced both the level of protein nitration and the extent
of IR injury [5]. Our present and prior studies, in which we measured
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ONOO−, i.e. DiTyr fluorescence, in the left ventricle [24] and in
coronary effluent [4], demonstrate that inhibiting NOS with L-NAME
can attenuate the increase in ONOO− induced during IR injury (Fig.
5B). To support these prior heart studies, we report here that L-NAME
also decreased IR-induced mitochondrial proteins tyr-N (Fig. 4A), while
improving functional recovery during reperfusion (Table 1). The rapid
fall in DiTyr fluorescence signal for ONOO− on reperfusion in isolated
hearts is due to washout of free DiTyr in the effluent. Overall, reducing
VDAC tyr-N by attenuating NO• generation, and thus ONOO−, by LNAME may play a supportive role in ameliorating IR injury.
To further evaluate the effects of mitochondrial protein tyr-N in
IR injury, we tested effects of an inhibitor/scavenger of RNS/ROS, i.e.
RES, on reducing protein tyr-N and improving functional recovery. RES
is purported to have anti-inflammatory, anti-aging, anti-neoplastic,
and cardioprotective properties [49]. RES may react directly with
ONOO− to act as a functional ONOO− scavenger in vitro and thereby to
prevent or mitigate ONOO−-induced tyr-N [50]. Although RES reduced
hypoxia-induced 𝑂2•− emission in cardiomyocytes has been reported
[51], RES treatment during ischemia in intact hearts involved
scavenging or inhibiting 𝑂2•− /ONOO−, with a subsequently decreased
mitochondrial protein tyr-N, has not been reported.
We report here for the first time that RES treatment partially
inhibited DHE fluorescence (emission of 𝑂2•− ) induced during ischemia,
and abolished it during reperfusion in intact perfused hearts, as well as
reduced mitochondrial protein tyr-N. Goh et al. [51] reported in
isolated perfused rat hearts that RES treatment during IR reduced LDH
release, improved post-ischemic recovery of LV function, and
increased Akt and p38MAPK activity. In our study, we also found that
RES, given just before ischemia and present in hearts during ischemia,
improved cardiac function after IR, which is consistent with the report
of Goh et al. [51]. In addition, our in vitro experiments with rVDAC
showed that RES directly, and completely, inhibited tyr-N of rVDAC
induced by ONOO− while L-NAME did not. Thus, RES is likely an
inhibitor of 𝑂2•− emission, and/or a scavenger of ONOO−; it not only
reduced tyr-N of mitochondrial proteins, specifically VDAC after IR
injury, but also improved cardiac contractility and relaxation. Although
RES has been shown to stimulate NOS to generate NO• when given to
precondition hearts against IR injury [43], it is likely in our
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experiments that much of NO• produced was converted to ONOO−
because of abundant 𝑂2•− , which then leads to nitration of VDAC.
We have implied that ONOO− is in large part responsible for the
observed tyr-N and that the major effect of ONOO− is to induce tyr-N.
Thus, limitations of our study are that ONOO− may induce PTMs of not
only tyr, but also of other aromatic residues and that tyr may be
additionally nitrated by non-ONOO− oxidants, such as other nitrites
and peroxidases.
In summary, we have identified VDAC as one of the
mitochondrial proteins that undergoes enhanced tyr-N during IR
injury. L-NAME and RES likely attenuate VDAC tyr-N in the ex vivo
model, but only RES abolished ONOO−-induced VDAC nitration in vitro,
because there was likely no NO• present. Moreover, inhibition of tyr-N
of VDAC by L-NAME, and especially by RES, not only demonstrates
that VDAC tyr-N occurs, but also that attenuating ONOO− production
reduces tyr-N of VDAC and concomitantly improves cardiac function
after IR. Tyr-N in ONOO−-treated rVDAC is selective and site-specific,
and was accompanied by rVDAC protein oligomerization. ONOO−treated rVDAC also leads to an enhanced channel conductance state.
The results obtained in this study indicate that VDAC, possibly with
other unidentified mitochondrial tyr-N proteins, plays a critical role in
mediating cardiac dysfunction during IR injury. Targeting against
specific protein tyr-N sites may represent a unique way to protect
mitochondrial proteins and organs against oxidative damage.
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ONLINE SUPPLEMENT MATERIAL
Tyrosine Nitration of Voltage Dependent Anion Channels
in Cardiac Ischemia-Reperfusion: Reduction by
Peroxynitrite Scavenging
Meiying Yang, Amadou K.S. Camara, Bassam T. Wakim, Yifan Zhou,
Ashish K. Gadicherla, Wai-Meng Kwok, David F. Stowe

Methods
Isolated heart preparation and protocols
Hearts were prepared for study as described previously [1-4].
The investigation was approved by the Medical College of Wisconsin
Institutional Animal Care and Use Committee. Guinea pigs were given
heparin (1000 units) and anesthetized with ketamine (50 mg/kg) i.p.
before sacrifice by decapitation. Hearts were removed and perfused at
constant pressure (55 mmHg) via the aortic root with an oxygenated
Krebs-Ringer’s (KR) solution of the following composition (in mmol/L):
138 Na+, 4.5 K+, 1.2 Mg2+, 2.5 Ca2+, 134 Cl-, 15 HCO3-, 1.2 H2PO4-,
11.5 glucose, 2 pyruvate, 16 mannitol, 0.1 probenecid, 0.05 EDTA,
and 5 U/L insulin and gassed with 3% CO2, 97% O2 (pH 7.4) at 37°C.
Systolic and diastolic left ventricular pressure (LVP) was measured
isovolumetrically with a transducer connected to a saline-filled latex
balloon placed in the LV through an incision in the left atrium. Diastolic
LVP was set to 0 mmHg initially as an increase during IR signifies
ventricular contracture. Coronary inflow (CF) was measured by an
ultrasonic flowmeter. Atrial and ventricular bipolar leads were placed
to measure spontaneous heart rate. The aortic inflow line was clamped
for 30 min to induce global ischemia. If ventricular fibrillation occurred
on reperfusion 250 µg of lidocaine was given via the aortic cannula to
restore sinus rhythm.
At the end of either 30 min ischemia (I), or 10, 30, or 60 min
reperfusion (R) hearts were removed and mitochondria were
immediately isolated for proteomic and other molecular studies. In the
treated groups either 100 µmol/L NG -nitro-L-arginine methyl ester (LNAME) or 10 µmol/L resveratrol (RES) was perfused for 10 min up to
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the initiation of global ischemia so that the drug remained in the heart
during ischemia. These concentrations were chosen because 10 µmol/L
of RES was reported to be cardioprotective in isolated rat hearts [5]
and 100 µmol/L of L-NAME blocked ONOO− production in cold (17°C)
perfused isolated hearts [2].

Detection of 𝑂2•− in isolated hearts loaded with DHE
Intracellular fluorescent probe dihydroethidium (DHE)
(Molecular Probes) was used to assess 𝑂2•− emission in the isolated
heart during IR. DHE is readily taken up by cells, and oxidized by 𝑂2•−
[6] to form 2-hydoxyethidium (2-OH-E+) and ethidium (Eth) [7]. 2OH-E+ is labile and the source of the variable fluorescence at the
emission wavelength of 590 nm (λem 590) when excited at 540 nm (λex
540) [7]. DHE and its derivatives are retained within cells with minimal
leakage [8].
This method for detecting 𝑂2•− with DHE in intact beating hearts
has been described by us previously [1-3, 9]. Isolated hearts are
perfused in a light-blocking Faraday cage. The distal end of a
trifurcated fiber-optic cable (optical surface area 3.85 mm2) is placed
against the LV free wall through an “O” ring-tightly sealed hole in the
tissue bath. Nylon netting is gently applied around the heart for
optimal contact with the fiber optic probe without impeding relaxation.
The fiber-optic cable is connected to a modified fluorescence
spectrophotometer (Photon Technology International, or SLM AmincoBowman II, Spectronic Instruments). Fluorescent emissions are
amplified by a photomultiplier tube (PMT) (700 V applied) and
recorded after excitation with a 150 W xenon arc lamp. The excitation
wavelength penetrates the thickness (4–5 mm) of the LV free wall.
Signals are recorded continuously during the entire experiment.
After attaining stability, hearts were loaded with 10 µmol/L of
DHE in KR solution for 20 min, followed by washout of residual DHE
with KR solution for another 20 min. DHE loaded hearts were treated
with/without RES/L-NAME before ischemia, followed by IR. DHE dye
loading increases fluorescence intensity from 0.3 ±0.01 arbitrary
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fluorescence units (afu) before dye loading to 2.2 ±0.2 afu after
washout of residual dye. The final DHE value after washout was
adjusted to 0 afu (baseline) to normalize the fluorescence intensity for
all experiments. Changes in DHE fluorescence signal, which represents
𝑂2•− generation, were compared to the baseline fluorescence signal
value.

Detection of ONOO− in isolated hearts loaded with L-tyrosine.
We have described in detail how to indirectly detect ONOO− in
isolated hearts [2]. In brief, dityrosine (DiTyr) fluorescence is used to
measure ONOO− formation using the same fiberoptic probe as for DHE
fluorescence. ONOO−, a product of 𝑂2•− and NO•, reacts with perfused
L-tyrosine to form the fluorescent dimer, DiTyr [10]. The reaction of Ltyrosine with ONOO− to produce DiTyr fluorescence occurs
immediately, and the product is stable at tissue pH [11]. L-tyrosine
(0.3 mmol/L) is added to the KR buffer, and unlike DHE, is present
throughout the experiment. Signal intensity is recorded continuously
at spectra λex 320 nm and λem 410 nm.
Fig. S1. Representative SDS-PAGE gel of anti-3-NT
immunoprecipitates from IR group. All immunoprecipitates were first
loaded into the loading wells, and then the gel was run at 150 V. After
all samples entered the separating gel part of SDS-PAGE gel, the gel
was run for an additional 5 min and then silver stained. Lane 1: anti-3NT immunoprecipitates; Lane 2: Marker; Part 1 and Part 2: collected
samples for LC-MS/MS assay.
Fig. S2. Assessment of VDAC and tyr-N of VADC spots on 2-DE gel.
Mitochondrial proteins from TC and IR10 groups were subjected to 2DE followed by Western blot with anti-3-NT antibody (A, B). After
probing with anti-3-NT, the membranes were stripped and reprobed
with VDAC antibody (C, D). Solid tilted arrows indicate the VDAC
positions. pH positions were determined according to the
manufacturer’s guide. WB: Western blot.
Fig. S3. 2-DE gel of rVDAC and rVDAC incubated with ONOO−. rVDAC
incubated without (control) or with 200 µmol/L ONOO− were subjected
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to 2-DE followed by Western blotting with anti-3-NT antibody (A, B).
After that the membranes were stripped and then blotted with antiVDAC antibody (C, D). pH positions were determined according to the
manufacturer’s guide. WB: Western blot.
Fig. S4. Characteristics voltage-dependence of rVDAC and native
VDAC in response to a ramp voltage protocol from -80 to +80 mV
under control conditions. rVDAC or native VDAC protein was added
into the cis chamber. After one channel was inserted into the planar
lipid bilayers, currents were recorded under voltage-clamp using a
voltage clamp amplifier (Axopatch 200B, Molecular Devices) and
recorded in 1 min segments.
Table S1. Proteins identified in anti-3-NT immunoprecipitates with LC-MS/MS.

Sequence information from the LC-MS/MS data was analyzed using Visualize software
(Brian Halligan, Medical College of Wisconsin). Protein Probability (Protein Probability
of 1 means 100%) and False Discovery Rate (FDR) were calculated automatically
using this program. All identified proteins met FDR less than 1.5%. Accession numbers
are quoted from Apropos, UniportKB/Swiss-port and PubMed. Band number refers to
the gel cut from Fig. S1.

Table S2. The full length of rat VDAC amino acids sequence.
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Residues in bold italic represented amino acids determined by our MALDI-TOF MS
analysis. Underlined residues represent a peptide fragment containing tyr-N residues
with a predicted mass of m/z 1693. * indicates the specific tyr-N residues.

Table S3. Cardiac function in time control (TC) non-ischemic, non treated group
over time.

Perfusion times 30 and 50 min are equivalent to 10 and 30 min ischemia and 60 min
reperfusion is equivalent to 10 min reperfusion after ischemia (see Table 1, Fig. 1).
Values are means ±SEM. sys-dia LVP: systolic-diastolic left ventricular pressure;
dLVP/dtmax: index of contractility; dLVP/dtmin: index of relaxation; N = 10 hearts;
average values for each variable did not change over time.
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Abbreviations
𝑂2•−

superoxide

NO•

nitric oxide

ONOO−

peroxynitrite

tyr

tyrosine

tyr-N

tyrosine nitration

IR

ischemia reperfusion

IP

immunoprecipitation

VDAC

voltage-dependent anion channel

RES

resveratrol

RNS

reactive nitrogen species

L-NAME NG nitro-L-arginine methyl ester
PTM

post translational modifications

ROS

reactive oxygen species

ETC

electron transport chain

3-NT

3-nitrotyrosine

DHE

dihydroethidium

DiTyr

dityrosine

LVP

left ventricular pressure
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PLB

planar lipid bilayers

Footnotes
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